Trevi Therapeutics, Inc. (TRVI) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $10.20M | -9.4% |
| 2024 | $11.26M | +64.2% |
| 2023 | $6.86M | -55.9% |
| 2022 | $15.56M | -27.3% |
| 2021 | $21.40M | +7.8% |
| 2020 | $19.85M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $10.20M | -9.4% |
| 2024 | $11.26M | +64.2% |
| 2023 | $6.86M | -55.9% |
| 2022 | $15.56M | -27.3% |
| 2021 | $21.40M | +7.8% |
| 2020 | $19.85M | — |